Exelixis Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Good afternoon, everyone. We're now on the third day of the SVB Securities Global Biopharma Conference. I'm Ken Shields, Vice President of Equity Research, helping to cover the targeted oncology universe of companies. I'm excited to have Exelixis join us, and we have Chris Senner, Executive Vice President and Chief Financial Officer; and Peter Lamb, Executive Vice President, Scientific Strategy here. Thank you both for spending some time with us.
Thanks for having us.
(Operator Instructions) So just jumping right in. Perhaps, you guys can start with a brief overview of Exelixis and help refresh those in the audience that may not be as familiar with the business.
Okay. So yes, thanks for having us, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
